STOCK TITAN

ChronoScale Holdings (CHRN) SEC Filings

CHRN NASDAQ

Ticker history: EKSO became CHRN (ChronoScale Holdings Corporation) on . Earlier news and filings retain their original names and dates. View EKSO history.

Rhea-AI Summary

ChronoScale Holdings Corp (CHRN) issued Applied Digital Corporation an unsecured $97.0 million convertible note, fully funded, as part of a private placement. Upon effectiveness of stockholder approval, the outstanding principal will automatically convert into 12,125,000 common shares at $8.00 per share, subject to adjustment for stock splits, combinations and reclassifications. The note carries no interest.

Assuming full conversion, Applied Digital may be deemed to beneficially own 85.6% of the common stock, or 151,653,227 shares, as of November 18, 2026, including shares held directly and indirectly through APLD ChronoScale Holdco LLC. ChronoScale reported 164,962,452 common shares outstanding as of November 20, 2026. If it has not converted, the note matures December 31, 2026; ChronoScale may not prepay before then without Applied Digital’s prior written consent.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

Applied Digital Corp., a 10% owner of ChronoScale Holdings Corp. (CHRN), purchased an unsecured convertible promissory note on November 18, 2026, with 12,125,000 underlying common shares at an $8.00 conversion price. No Rule 10b5-1 plan is reported, and the reported price figure is not usable as a per-share price. Conversion is conditioned on stockholder approval and an information statement being mailed and remaining outstanding for at least 20 calendar days. If it does not convert, the note matures December 31, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

ChronoScale Holdings Corporation (CHRN) amended its prior transaction report, adding agreements and supplementing details on a financing and contribution closing. On November 18, 2026, the company closed transactions under its Common Stock Purchase Agreement, issuing approximately 19.1 million common shares for $153.0 million in aggregate gross proceeds and issuing a convertible note to Applied Digital Corporation. It also delivered an initial put notice for Series C preferred shares with a $10.0 million aggregate purchase price.

At the Contribution Closing, OD1 JV Holdings LLC entered a term loan agreement with Macquarie Equipment Capital Inc., became provider under the GPU Services Agreement, and issued a convertible note to ChronoScale Member. ChronoScale issued a warrant to STN and entered an assignment and exchange agreement with APLD Intermediate Holdco LLC.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.08%
Tags
current report
Rhea-AI Summary

ChronoScale Holdings Corp (CHRN) attached an investor presentation shared with prospective investors in connection with its Common Stock Private Placement. The presentation is dated November 18, 2026 and is incorporated by reference.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.75%
Tags
current report
-
Rhea-AI Summary

ChronoScale Holdings Corp. (CHRN) agreed to a common-stock placement of approximately 19.1 million shares at $8.00 each, with expected gross proceeds of $153.0 million and closing expected November 18, 2026. A separate preferred-stock facility permits purchases of up to $500 million, subject to conditions; an initial $10.0 million put was expected. ChronoScale also issued Applied Digital a funded, unsecured $97.0 million convertible note, automatically convertible at $8.00 per share when stockholder approval becomes effective and due December 31, 2026.

The planned Odessa partnership with STN is structured as a 50/50 venture, subject to closing conditions and HSR clearance. ChronoScale's subsidiary is to fund a $220 million partnership note that automatically converts into 50% of partnership units after HSR clearance. The partnership is also to borrow $74,687,500 under a term loan at 10% annual interest, paid in kind and maturing 90 days after closing.

The GPU services agreement has expected contract value of up to $7.5 billion over approximately six years, assuming full performance and delivery of contracted capacity; this excludes extension periods and optional additional tranches. Services are divided into four tranches. A customer may terminate affected tranches for certain delivery delays or sustained service-level failures, with cure rights potentially available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.75%
Tags
current report
-
Rhea-AI Summary

ChronoScale Holdings Corp reported results of its November 6, 2026 annual meeting. Shareholders elected Wes Cummins, Ella Benson, Ying Cenly Chen, William M. Clancy, Douglas Miller, Richard Nottenburg and Andrew Schaap to serve until the 2027 annual meeting, or until a successor is elected and qualified or the director is otherwise unable to complete the term.

Shareholders cast 142,417,127 votes for ratifying CBIZ CPAs P.C. as the independent registered public accounting firm for the fiscal year ending May 31, 2027. Advisory executive compensation received 141,001,650 votes for and 53,135 against; ratification of certain restricted stock awards to non-employee directors received 140,412,964 for and 642,461 against. The adjournment proposal received 141,565,630 votes for and 815,179 against.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.09%
Tags
current report
Rhea-AI Summary

ChronoScale Holdings Corporation (CHRN) reported fiscal first-quarter 2027 revenue of $41.5 million for the quarter ended August 31, 2026, up 148% from $16.7 million in the prior-year comparable period. Net loss from continuing operations was $26.4 million, compared with $11.2 million in fiscal first quarter 2026; adjusted EBITDA, a non-GAAP measure, was $5.9 million versus $9.4 million. Cash and cash equivalents were $15.2 million as of August 31, 2026.

ChronoScale secured a 50 MW AI compute deployment with Microsoft in North America and entered strategic partnerships with Nutanix and Baseten. The three-year Baseten partnership supports a planned deployment of approximately 4 MW, with completion expected in calendar Q1 2027. ChronoScale received $328.2 million in aggregate prepayments under existing customer contracts and said it was on track for $1 billion in annualized run-rate revenue by calendar Q3 2027; that operating metric is based on current assumptions, is not a forecast of revenue for any specific reporting period, and actual revenue may differ materially.

On September 30, 2026, ChronoScale completed the sale of the Legacy Ekso Business. Its results were excluded from continuing operations and reported separately as discontinued operations; net loss from discontinued operations was $16.1 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.04%
Tags
current report
-
Rhea-AI Summary

ChronoScale Holdings Corp. (CHRN) reported revenue of $41.482 million for the three months ended August 31, 2026, versus $16.718 million a year earlier. Net loss was $42.484 million, including $16.054 million from discontinued operations; continuing-operations net loss was $26.430 million. Operating cash flow was $14.625 million, versus $95,000 a year earlier.

Two GPU services agreements have three-year committed terms and $2.7 billion in aggregate contracted revenue. Deployments are partly subject to financing and customary conditions and milestones. The company is contractually committed to approximately $2.3 billion in project capital expenditures during the 12-month look-forward period, and $2.0 billion in purchase obligations are expected to be paid within one year. ChronoScale recorded a $14.126 million impairment loss related to the Legacy Ekso business, whose sale closed September 30, 2026.

A working-capital deficit of approximately $70.5 million as of August 31, 2026 raised substantial doubt about going concern. Management concluded its plans were probable to be implemented within the 12-month look-forward period and would provide sufficient liquidity to fund project-related capital outlays and maintain run-rate operations, alleviating that doubt.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.86%
Tags
quarterly report
-
EFFECT
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.78%
Tags
other
Rhea-AI Summary

ChronoScale Holdings Corp (CHRN) director Scott G. Davis acquired 51,626 restricted stock units (RSUs) on October 2, 2026; they vested in full that day. Each RSU represents the right to receive one common share, and settlement has been deferred under the award agreement. After the grant, Davis's reported direct holdings were 239,760 shares, with 373 shares held indirectly through a 401(k). The RSUs were granted in connection with the consummation of the disposition of Ekso Bionics, Inc., a wholly owned subsidiary. Davis resigned from the board effective October 3, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.54%
Tags
insider

FAQ

How many ChronoScale Holdings (CHRN) SEC filings are available on StockTitan?

StockTitan tracks 52 SEC filings for ChronoScale Holdings (CHRN), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for ChronoScale Holdings (CHRN)?

The most recent SEC filing for ChronoScale Holdings (CHRN) was filed on November 20, 2026.